DIFFERENTIAL BLOCKADE OF ALPHA-ADRENOCEPTORS BY INDORAMIN

被引:18
作者
NICHOLLS, DP
OCONNOR, PC
HARRON, DWG
LEAHEY, WJ
SHANKS, RG
机构
关键词
D O I
10.1111/j.1365-2125.1984.tb02409.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:719 / 728
页数:10
相关论文
共 60 条
[1]   ACTION OF INDORAMIN ON PRESYNAPTIC AND POSTSYNAPTIC ALPHA-ADRENOCEPTORS IN PITHED RATS [J].
ALGATE, DR ;
WATERFALL, JF .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1978, 30 (10) :651-652
[2]   CARDIOREGULATORY PROPERTIES OF INDORAMIN IN THE RAT [J].
ALGATE, DR ;
RASHID, S ;
WATERFALL, JF .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (04) :236-239
[3]   QUANTITATIVE ANALYSIS ON ISOLATED ORGANS OF AUTONOMIC BLOCKING PROPERTIES OF INDORAMIN HYDROCHLORIDE (WY 21901) [J].
ALPS, BJ ;
WILSON, AB ;
JOHNSON, ES ;
HILL, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1972, 44 (01) :52-&
[4]   EVIDENCE AGAINST PRESYNAPTIC ALPHA-ADRENORECEPTOR MODULATION OF CARDIAC SYMPATHETIC TRANSMISSION [J].
ANGUS, JA ;
KORNER, PI .
NATURE, 1980, 286 (5770) :288-291
[5]   ALPHA-ADRENERGIC BLOCKING ACTIVITY OF PRAZOSIN - EFFECT ON CATECHOLAMINE LEVELS AND CATECHOLAMINE SYNTHETIC ENZYMES [J].
ATKINS, FL ;
NICOLOSI, GL .
BIOCHEMICAL PHARMACOLOGY, 1979, 28 (07) :1233-1237
[6]   CENTRAL AND PERIPHERAL CONTRIBUTION TO ANTIHYPERTENSIVE ACTION OF INDORAMIN [J].
BAUM, T ;
SHROPSHIRE, AT .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1975, 32 (01) :30-38
[7]   VARIATIONS IN INDIVIDUAL ORGAN RELEASE OF NORADRENALINE MEASURED BY AN IMPROVED RADIOENZYMATIC TECHNIQUE - LIMITATIONS OF PERIPHERAL VENOUS MEASUREMENTS IN THE ASSESSMENT OF SYMPATHETIC NERVOUS ACTIVITY [J].
BROWN, MJ ;
JENNER, DA ;
ALLISON, DJ ;
DOLLERY, CT .
CLINICAL SCIENCE, 1981, 61 (05) :585-590
[8]  
CAMBRIDGE D, 1977, BRIT J PHARMACOL, V59, pP514
[9]   EPINEPHRINE PLASMA METABOLIC-CLEARANCE RATES AND PHYSIOLOGIC THRESHOLDS FOR METABOLIC AND HEMODYNAMIC ACTIONS IN MAN [J].
CLUTTER, WE ;
BIER, DM ;
SHAH, SD ;
CRYER, PE .
JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (01) :94-101
[10]   CLINICAL PHARMACOLOGICAL STUDIES OF INDORAMIN IN MAN [J].
COLTART, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 :S49-S60